Retinal Imaging in Patients With Inherited Retinal Degenerations

Sponsor
University of California, San Francisco (Other)
Overall Status
Recruiting
CT.gov ID
NCT00254605
Collaborator
University of California, Berkeley (Other)
400
1
228
1.8

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether the structure and function of the human retina can be studied with high resolution in patients with inherited retinal degenerations using the Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Retinal degenerations are a group of inherited diseases that result in progressive death of the vision cells, or photoreceptors. Currently there is no treatment or cure for any of these diseases and they ultimately cause blindness in affected patients. We propose to investigate the structure and function of the human retina in patients with inherited retinal degenerations using the Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO). We will correlate the images of retinal structure produced by the AOSLO with Optical Coherence Tomography (OCT) images of the retina. In addition, we will study the vision of individual photoreceptors using the AOSLO to perform a novel technique, microperimetry, in patients with retinal degenerations. We will compare the results of microperimetry with standard measures of vision used in Ophthalmology clinics, including visual acuity, automated perimetry, fundus photography and multifocal electroretinography (mfERG).

    The results of this work will provide insight into the mechanism of vision loss among patients with diverse retinal disorders. Specifically, we will study cone structure and function in patients with retinal degenerations with different etiologies: retinitis pigmentosa, a disease usually caused by rod-specific mutations; cone-rod dystrophy, which primarily affects cones rather than rods; and Best's disease, a disease caused by a defect in the retinal pigment epithelium (RPE). In addition, we will study the effect that lipofuscin, a byproduct of photoreceptor metabolism that accumulates in the RPE in diseases such as Stargardt's disease, Best's disease and age-related macular degeneration (AMD), has on cone structure and function, with the goal of understanding how these diseases cause blindness. Better understanding of the mechanisms of vision loss in patients with retinal degeneration should ultimately lead to treatments for these blinding conditions.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    400 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    High Resolution Retinal Imaging in Patients With Inherited Retinal Degenerations
    Study Start Date :
    Nov 1, 2005
    Anticipated Primary Completion Date :
    Oct 1, 2023
    Anticipated Study Completion Date :
    Nov 1, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Cone spacing [24 months]

      The current study will assess cone spacing twice at baseline and every 6 months for 30 months. The primary outcome will be measured at 24 months.

    Secondary Outcome Measures

    1. Visual acuity [24 months]

      Visual acuity will be measured every 6 months for 30 months with the primary outcome measure at 24 months.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Subjects must speak and understand English

    • Subjects must have pupils that dilate to at least 6 millimeters diameter.

    • Subjects must be willing to travel to UC Berkeley.

    • Subjects are financially responsible for their travel to the San Francisco area if they are not San Francisco residents.

    Exclusion Criteria:
    • Cataract

    • Irregular corneal astigmatism (keratoconus)

    • Prior refractive surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Ophthalmology Retinal Degenerations Clinic, UCSF San Francisco California United States 94143

    Sponsors and Collaborators

    • University of California, San Francisco
    • University of California, Berkeley

    Investigators

    • Principal Investigator: Jacque L. Duncan, M.D., University of California, San Francisco

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of California, San Francisco
    ClinicalTrials.gov Identifier:
    NCT00254605
    Other Study ID Numbers:
    • H12225-27221-0+1
    First Posted:
    Nov 16, 2005
    Last Update Posted:
    Sep 29, 2021
    Last Verified:
    Sep 1, 2021
    Keywords provided by University of California, San Francisco
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 29, 2021